Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MESNA vs METFORMIN\SAXAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MESNA vs METFORMIN\SAXAGLIPTIN: Safety Overview

Metric MESNA METFORMIN\SAXAGLIPTIN
Total FAERS Reports 4,892 1,093
Deaths Reported 1,029 117
Death Rate 21.0% 10.7%
Hospitalizations 2,155 336
Average Patient Age 39.3 yrs 61.4 yrs
% Female Patients 46.8% 50.0%
FDA Approval Date Apr 13, 2010 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A